Insmed
INSM
415 hedge funds and large institutions have $13.7B invested in Insmed in 2024 Q3 according to their latest regulatory filings, with 74 funds opening new positions, 184 increasing their positions, 115 reducing their positions, and 38 closing their positions.
95% more first-time investments, than exits
New positions opened: 74 | Existing positions closed: 38
82% more capital inflows, than outflows
Capital inflows: $2.18B | Capital outflows: $1.2B
60% more repeat investments, than reductions
Existing positions increased: 184 | Existing positions reduced: 115
10% more funds holding
Funds holding: 378 → 415 (+37)
0.7% more ownership
Funds ownership: 108.69% → 109.39% (+0.7%)
0% more funds holding in top 10
Funds holding in top 10: 27 → 27 (0)
35% less call options, than puts
Call options by funds: $173M | Put options by funds: $268M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$513M |
| 2 |
State Street
Boston,
Massachusetts
|
+$112M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$83.4M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
+$68M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$65.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deep Track Capital
Greenwich,
Connecticut
|
-$134M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
-$77.4M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$69.4M |
| 4 |
Suvretta Capital Management
New York
|
-$65.4M |
| 5 |
Millennium Management
New York
|
-$46.8M |
INSM Hedge Fund Activity: Q3 2024 in Review
415 of the 6,990 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q3 2024, worth a combined $13.7B — up 17% from $11.7B a quarter earlier.
Buyers outnumbered sellers: 74 funds opened new INSM positions and 38 closed out — a net gain of 36 holders — while 184 added to existing stakes and 115 trimmed.
The largest buyer was Darwin Global Management, adding an estimated $513M. The largest seller was Deep Track Capital, exiting entirely with an estimated $134M sold.
- 415 institutional investors held Insmed (INSM) as of Q3 2024, up from 378 in Q2 2024.
- Funds reported $13.7B of Insmed stock for Q3 2024, up 17% quarter-over-quarter.
- 74 funds opened new Insmed positions in Q3 2024 and 38 closed out, a net change of +36 holders.
- The largest Insmed buyer in Q3 2024 was Darwin Global Management, an estimated $513M added.
- The largest Insmed seller in Q3 2024 was Deep Track Capital, an estimated $134M sold.
Based on aggregated 13F filings for Q3 2024.